The Albanese Government has released its 2023-24 Mid-Year Economic Fiscal Outlook, which includes $3.5 billion since the May Budget for new medicines on the PBS, but also an expected decline in spending on the program that must be qualified because the estimate does not include the impact of future new listings. …
Update reveals significant spending on new listings since the May Budget
December 13, 2023 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
A 'fit for purpose' HTA system will be accompanied by a 'fit for purpose' cost recovery framework
December 19, 2025 - - Latest News -
Cleo Diagnostics raises funds to accelerate US launch and advance ovarian cancer screening
December 18, 2025 - - Australian Biotech -
Actinogen crosses key milestone as pivotal Alzheimer’s trial fully enrols
December 18, 2025 - - Australian Biotech -
Pharmac scraps plan to remove low-ranked medicines from options for funding list
December 18, 2025 - - Latest News -
PBAC reflects on a year shaped by major reviews and rising workload
December 18, 2025 - - Latest News -
Priceline moves to stabilise banner group as pressures force administrators
December 17, 2025 - - Latest News -
Rare Cancers Australia gearing up for 2026 Kosi Challenge with Pharma Cup up for grabs again
December 17, 2025 - - Latest News